Ploeg R J, Vreugdenhil P, Goossens D, McAnulty J F, Southard J H, Belzer F O
Department of Surgery, University of Wisconsin, Madison 53792.
Surgery. 1988 Jun;103(6):676-83.
We examined how a combination of pharmacologic agents ("rescue" agents) affect the function of hypothermically preserved dog kidneys at the time of reperfusion. Dog kidneys were preserved either by simple cold storage in EuroCollins' solution for 24 or 48 hours or by continuous perfusion at 5 degrees C in Belzer's gluconate-hydroxyethyl starch solution for as long as 5 days. After preservation, renal functions were measured with the isolated perfused kidney model. Kidneys were reperfused at normothermia either with or without the addition of a combination of rescue agents to the reperfusion medium. The rescue agents studied were allopurinol (1 mmol/L); superoxide dismutase (32,000 U/L); catalase (137,500 U/L); dimethylthiourea (3 mmol/L); glutathione (3 mmol/L); desferrioxamine (0.2 gm/L), for protection against O2 free radical injury and lipid peroxidation injury; verapamil (25 mg/L), as a Ca channel blocker; and ATP-MgCl2 (0.3 mmol/L), to stimulate energy metabolism. The renal functions we measured were glomerular filtration rate (GFR) (creatinine clearance), urine production, perfusate flow, urinary protein concentration, Na reabsorptive capacity, and tissue concentrations of ATP, K, and total tissue water. GFR was reduced by 75% to 90% after all periods of preservation, and the rescue agents had no effect on GFR. Sodium reabsorption was reduced from 98% to a range of 40% to 50% after 48 hours of cold storage or 5 days of machine perfusion and was not increased by rescue agents. There was a time-dependent increase in the amount of urine protein that was not affected by rescue agents. The addition of rescue agents did not affect total tissue water or concentrations of ATP or K in kidneys after normothermic reperfusion. These results demonstrate that pharmacologic agents previously suggested to suppress reperfusion damage in kidneys are not effective in this model. Therefore it is likely that kidneys damage occurs primarily during preservation, which suggest that optimal function on reperfusion calls for the development of better methods of preservation.
我们研究了多种药物制剂(“挽救”制剂)的组合在再灌注时如何影响低温保存的犬肾的功能。犬肾的保存方式有两种:一是在EuroCollins液中简单冷藏24或48小时;二是在5℃下于Belzer氏葡萄糖酸盐 - 羟乙基淀粉溶液中持续灌注长达5天。保存后,使用离体灌注肾模型测量肾功能。在常温下对肾进行再灌注时,再灌注液中添加或不添加挽救制剂组合。所研究的挽救制剂包括:别嘌呤醇(1 mmol/L);超氧化物歧化酶(32,000 U/L);过氧化氢酶(137,500 U/L);二甲基硫脲(3 mmol/L);谷胱甘肽(3 mmol/L);去铁胺(0.2 g/L),用于预防氧自由基损伤和脂质过氧化损伤;维拉帕米(25 mg/L),作为钙通道阻滞剂;以及ATP - MgCl2(0.3 mmol/L),用于刺激能量代谢。我们测量的肾功能包括肾小球滤过率(GFR)(肌酐清除率)、尿量、灌注液流量、尿蛋白浓度、钠重吸收能力以及ATP、钾和组织总含水量的组织浓度。在所有保存期后,GFR降低了75%至90%,挽救制剂对GFR没有影响。冷藏48小时或机器灌注5天后,钠重吸收从98%降至40%至50%的范围,且挽救制剂未使其增加。尿蛋白量随时间增加,不受挽救制剂影响。常温再灌注后,添加挽救制剂对肾组织总含水量、ATP或钾的浓度没有影响。这些结果表明,先前认为可抑制肾再灌注损伤的药物制剂在该模型中无效。因此,肾损伤可能主要发生在保存期间,这表明再灌注时的最佳功能需要开发更好的保存方法。